Romulus Breban

Dr. Romulus Breban

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2020 in Bulletin of the World Health Organization
Verified
Journal Article
Open access
RGRebecca Grant
Rebecca Grant
LNLiem-Binh Luong Nguyen
Liem-Binh Luong Nguyen
RBRomulus Breban
Romulus Breban

10 April 2009 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
RBRomulus Breban
Romulus Breban
JDJohn Drake
John Drake
DSDavid E. Stallknecht
David E. Stallknecht
PRPejman Rohani
Pejman Rohani
Avian influenza virus (AIV) persists in North American wild waterfowl, exhibiting major outbreaks every 2–4 years. Attempts to explain the patterns of periodicity and persistence using simple direct transmission models are unsuccessful. Motivated by empirical evidence, we examine the contribution of an overlooked AIV transmission mode: environmental transmission. It is known that infectious birds shed large concentrations of virions in the environment, where virions may persist for a long time. We thus propose that, in addition to direct fecal/oral transmission, birds may become infected by ingesting virions that have long persisted in the environment. We design a new host–pathogen model that combines within-season transmission dynamics, between-season migration and reproduction, and environmental variation. Analysis of the model yields three major results. First, environmental transmission provides a persistence mechanism within small communities where epidemics cannot be sustained by direct transmission only (i.e., communities smaller than the critical community size). Second, environmental transmission offers a parsimonious explanation of the 2–4 year periodicity of avian influenza epidemics. Third, very low levels of environmental transmission (i.e., few cases per year) are sufficient for avian influenza to persist in populations where it would otherwise vanish. Avian influenza viruses (AIVs) in wild waterfowl constitute the historic source of human influenza viruses, having a rich pool of genetic and antigenic diversity that often leads to cross-species transmission. Although the emergence of H5N1 avian influenza virus onto the international scene has captured the most attention, we do not as yet understand the mechanisms that underpin AIV persistence and dynamics in the wild. We developed a novel host–pathogen model intended to describe the epidemiology of low pathogenic AIV in temperate environments. Our model takes into account seasonality in migration and breeding together with multiple modes of transmission. AIVs have been detected in unconcentrated lake water, soil swabs, and mud samples. Laboratory experiments show that AIVs persist and remain infectious in water for extended periods. However, so far, the possibility of environmental transmission of AIV has been largely overlooked. Our work shows that environmental transmission provides a parsimonious explanation for the patterns of persistence and outbreaks of AIV documented in the literature. In addition to their scientific importance, our conclusions impact the design of control policies for avian influenza by emphasizing the dramatic and long-term role that environmental persistence of pathogens may play at the epidemic level.

1 March 2012 in Journal of Mathematical Biology
Verified
Journal Article
Closed access
PDF file
RBRomulus Breban
Romulus Breban

13 September 2012 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
RBRomulus Breban
Romulus Breban
WDW. Doss
W. Doss
GEG. Esmat
G. Esmat
MEM. Elsayed
M. Elsayed
MHM. Hellard
M. Hellard
MMM. K. Mohamed
M. K. Mohamed

1 June 2010 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
RBRomulus Breban
Romulus Breban
JDJohn Drake
John Drake
PRPejman Rohani
Pejman Rohani

1 September 2014 in The Lancet Global Health
Verified
Journal Article
Open access
RBRomulus Breban
Romulus Breban
NANaglaa Arafa
Naglaa Arafa
SLSandrine Leroy
Sandrine Leroy
AMAya Mostafa
Aya Mostafa
IBIman Bakr
Iman Bakr
AFArnaud Fontanet
Arnaud Fontanet
Most hepatitis C virus (HCV) transmission in Egypt is related to medical injections and procedures. To control the spread of HCV, the Egyptian Ministry of Health initiated awareness and education campaigns, strengthened infection control in health-care facilities, and subsidised anti-HCV treatment. We aimed to investigate the effect of these interventions on the spread of HCV by mathematical modelling. We developed a mathematical model of HCV transmission in Zawyat Razin, a typical rural community. Our model assumes that each individual has two distinct types of medical procedures: injections and more invasive medical procedures. To quantify the severity of the spread of HCV, we used the notion of the basic reproduction number R0, a standard threshold parameter signalling whether transmission of an infectious disease is self-sustained and maintains an epidemic. If R0 is greater than 1, HCV is self-sustained; if R0 is 1 or less, HCV transmission is not self-sustained. We investigated whether heterogeneity in the rate of injection or invasive medical procedures is the determinant factor for HCV transmission and whether most iatrogenic transmission is caused by a small group of individuals who receive health-care interventions frequently. We then assessed whether interventions targeted at this group could reduce the spread of HCV. The R0 of the spread of HCV without treatment was 3·54 (95% CI 1·28-6·18), suggesting a self-sustained spread. Furthermore, the present national treatment programme only decreased R0 from 3·54 to 3·03 (95% CI 1·10-5·25). Individuals with high rates of medical injections seem to be responsible for the spread of HCV in Egypt; the R0 of the spread of HCV without treatment would be 0·64 (95% CI 0·41-0·93) if everybody followed the average behaviour. The effect of treatment on HCV transmission is greatly enhanced if treatment is provided a mean of 2·5 years (95% CI 0·1-9·2) after chronic infection and with drug regimens with more than 80% efficacy. With these treatment parameters, preventive and curative interventions targeting individuals with high rates of medical injections might decrease R0 below 1 for treatment coverage lower than 5%. Targeting preventive and curative interventions to individuals with high rates of medical injections in Egypt would result in a greater reduction the spread of HCV than would untargeted allocation. Such an approach might prove beneficial in other resource-limited countries with health-care-driven epidemics. Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS 1211), ANR grant Labex Integrative Biology of Emerging Infectious Diseases.